In all three studies, enrichment of SRSF3-dependent SEs was seen with NAFLD (NAS, steatosis, ballooning) but not in NASH (fibrosis, inflammation) suggesting that changes in SRSF3-dependent splicing occur early in liver disease. This evidence concerns the gene SRSF3 and metabolic dysfunction-associated steatotic liver disease.